We are live on !
Find out more
Bartlett & Co Portfolio holdings
AUM
$6.16B
Turnover
12.86%
1-Year Est. Return
20.29%
This Fund
S&P 500
This Quarter Est. Return
+10.4%
1 Year Est. Return
+20.29%
3 Year Est. Return
+30.84%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$6.16B
AUM Growth
+$590M
(+11%)
Cap. Flow
+$26M
Cap. Flow % of AUM
Cap. Flow %
0.42%
Top 10 Holdings %
Top 10 Hldgs %
30.5%
Holding
1,314
New
118
Increased
226
Reduced
290
Closed
51
Avg Time Held
3.3
years
Top 10 Avg Time Held
4.2
years
Top 20 Avg Time Held
5.7
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Chevron
CVX
|
+$26.9M |
| 2 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$11.7M |
| 3 |
Procter & Gamble
PG
|
+$11M |
| 4 |
McCormick & Company Non-Voting
MKC
|
+$10M |
| 5 |
JPMorgan US Quality Factor ETF
JQUA
|
+$9.04M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Enbridge
ENB
|
+$47.6M |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$12.7M |
| 3 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$7.97M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$5.21M |
| 5 |
NextEra Energy
NEE
|
+$4.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.28% |
| 2 | Miscellaneous | 17.67% |
| 3 | Healthcare | 12.33% |
| 4 | Financials | 11.49% |
| 5 | Industrials | 9.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
701
DELISTED
Annaly Capital Management Series I
NLY.PRI
| $49K | ﹤0.01% |
+2,000
| New | +$47.7K |
2023 Q4
0 quarters
|
|
702
Bitwise 10 Crypto Index ETF
BITW
$793M
| $49K | ﹤0.01% |
2,000
| – | – |
2022 Q1
7 quarters
|
|
703
DELISTED
Qorvo
QRVO
| $48K | ﹤0.01% |
418
| – | – |
2023 Q2
2 quarters
|
|
704
Archer Daniels Midland
ADM
$38.8B
| $47K | ﹤0.01% |
656
-200
| -23% | -$14.6K |
2022 Q1
7 quarters
|
|
705
Cushman & Wakefield Ltd
CWK
$2.7B
| $47K | ﹤0.01% |
4,270
| – | – |
2022 Q1
7 quarters
|
|
706
HubSpot
HUBS
$12.5B
| $47K | ﹤0.01% |
80
| – | – |
2022 Q1
7 quarters
|
|
707
DELISTED
Inspire Veterinary Partners
IVP
| $47K | ﹤0.01% |
52
-7
| -12% | -$12.2K |
2023 Q3
1 quarter
|
|
708
Carlyle Group
CG
$13.3B
| $46K | ﹤0.01% |
1,101
| – | – |
2023 Q2
2 quarters
|
|
709
State Street SPDR S&P Regional Banking ETF
KRE
$3.46B
| $46K | ﹤0.01% |
873
-38,205
| -98% | -$1.71M |
2022 Q1
7 quarters
|
|
710
MasterBrand
MBC
$1.36B
| $46K | ﹤0.01% |
3,050
| – | – |
2022 Q4
4 quarters
|
|
711
O'Reilly Automotive
ORLY
$72.8B
| $46K | ﹤0.01% |
735
+45
| +7% | +$2.84K |
2022 Q1
7 quarters
|
|
712
Eaton Vance Tax-Managed Global Diversified Equity Income Fund
EXG
$2.89B
| $45K | ﹤0.01% |
5,750
| – | – |
2022 Q1
7 quarters
|
|
713
FirstEnergy
FE
$26.5B
| $45K | ﹤0.01% |
1,221
| – | – |
2022 Q1
7 quarters
|
|
714
iShares Core High Dividend ETF
HDV
$15.7B
| $45K | ﹤0.01% |
2,195
+1,325
| +152% | +$26.1K |
2022 Q1
7 quarters
|
|
715
Home BancShares
HOMB
$5.88B
| $45K | ﹤0.01% |
1,769
| – | – |
2022 Q1
7 quarters
|
|
716
PPL Corp
PPL
$26B
| $45K | ﹤0.01% |
1,619
-1,235
| -43% | -$31.3K |
2022 Q1
7 quarters
|
|
717
Uber
UBER
$141B
| $45K | ﹤0.01% |
712
+495
| +228% | +$25.9K |
2022 Q1
7 quarters
|
|
718
Dimensional Emerging Core Equity Market ETF
DFAE
$9.6B
| $44K | ﹤0.01% |
+1,832
| New | +$41.9K |
2023 Q4
0 quarters
|
|
719
Invesco Russell 1000 Equal Weight ETF
EQAL
$814M
| $44K | ﹤0.01% |
1,000
| – | – |
2023 Q2
2 quarters
|
|
720
Gentex
GNTX
$4.48B
| $44K | ﹤0.01% |
1,350
| – | – |
2022 Q1
7 quarters
|
|
721
Lam Research
LRCX
$330B
| $44K | ﹤0.01% |
550
-80
| -13% | -$5.45K |
2022 Q1
7 quarters
|
|
722
Invesco Pharmaceuticals ETF
PJP
$564M
| $44K | ﹤0.01% |
574
| – | – |
2022 Q1
7 quarters
|
|
723
TC Energy
TRP
$64.4B
| $44K | ﹤0.01% |
1,113
| – | – |
2022 Q1
7 quarters
|
|
724
Barings BDC
BBDC
$871M
| $43K | ﹤0.01% |
+5,000
| New | +$44.5K |
2023 Q4
0 quarters
|
|
725
Black Hills Corp
BKH
$5.91B
| $43K | ﹤0.01% |
800
| – | – |
2023 Q2
2 quarters
|
|
Similar funds
Bartlett & Co's Q4 2023 Portfolio in Review
As of Q4 2023, Bartlett & Co held 1,314 positions worth $6.16B, up 11% from $5.57B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Bartlett & Co's Q4 2023 filing shows 118 new, 226 increased, 290 reduced and 51 closed positions. Its largest new stake was JPMorgan US Quality Factor ETF: 201,376 shares worth $9.7M. The largest sale was Enbridge, an estimated $47.6M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Miscellaneous and Healthcare.
- Bartlett & Co's largest Q4 2023 buy was JPMorgan US Quality Factor ETF: 201,376 shares worth $9.7M.
- Bartlett & Co added most to Chevron in Q4 2023, an estimated $26.9M increase.
- Bartlett & Co's biggest Q4 2023 reduction was Enbridge, cutting an estimated $47.6M.
- Bartlett & Co fully exited Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2023, selling an estimated $7.97M.
- Bartlett & Co's ten largest holdings make up 30% of its $6.16B portfolio in Q4 2023.
- Bartlett & Co opened 118 new positions and closed 51 in Q4 2023.
- Bartlett & Co's portfolio value rose 11% quarter-over-quarter to $6.16B.
Based on Bartlett & Co's 13F filing for Q4 2023, filed 8 Jan 2024.